Background To examine the associations between levels of severity of mental distress (MD) and meeting the 2008 physical activity (PA) recommendations using the MD Severity Index (MDSI).
Introduction
Mental distress (MD) is a significant public health concern both nationally 1 and internationally. 2 Prevalence of MD is estimated to be~9.4% in United States (US) adults based on data from the 1993-2001 and 2003-06 Behavioral Risk Factor Surveillance System (BRFSS). 3 Several studies have revealed a harmful relationship between components of MD and cardiovascular disease (CVD), [4] [5] [6] diabetes, [4] [5] [6] participation in certain deleterious behaviors [7] [8] [9] and other metabolic risk factors. 6, 8 MD (or frequent MD [FMD] ), commonly defined as reporting ≥14 days/month of poor mental health, is characterized by stress, depression and problems with emotions. 10 The cut-point used to define MD is comparable to other diagnostic tools, such as the Center for Epidemiologic Studies Depression Scale Revised (CESD-R), 11 used to diagnose clinical depression and certain anxiety disorders. Several studies investigating the associations between MD and disease, physical activity (PA), and health behaviors have utilized this 14-day cut-point.
PA has been shown to be inversely associated with MD in several cross-sectional studies. 7, 9, [12] [13] [14] Moreover, it is postulated that there is a bidirectional relationship between poor mental health and activity participation, indicating that the causal pathway between poorer mental health and low activity may come from either direction. [15] [16] [17] [18] Using data from the 2001 BRFSS, Brown et al. 12 reported significantly lower odds (P < 0.05) of reporting ≥14 days/month of MD when reporting any level of PA compared to those reporting none. These associations were consistent across all age groups. Similarly, Strine and colleagues 9 revealed significantly increased odds (odds ratio [OR] = 1.6, 95% CI: 1.5-1.7) of being physically inactive when reporting ≥14 days/month of MD. Kobau et al.
14 reported a higher mean days/month of MD (3.9 days/ month, 95% CI: 3.8-4.1) in those reporting no PA compared to those reporting PA participation (2.6 days/month, 95% CI: 2.5-2.7).
While research has shown associations between PA and MD and other health behaviors, there is a need for a more nuanced examination of MD to better understand the associations between various levels of MD and health behaviors. A recent study conducted by Bossarte et al. 19 investigated the validity of the single MD cut-point in BRFSS using validated mental health measures in order to establish an optimal MD cut-point. A higher combined sensitivity and specificity at a frequency of 6 days of reported MD was found, compared to the 14-day cut-point, suggesting a lower threshold for MD as well as stronger associations with clinical depression and poor mental health. The study indicates various levels of MD impacts individuals differently; therefore, it is prudent to continue to examine associations between levels of MD and health outcomes.
One way of doing this is to move beyond dichotomous cut-points by using a variable, such as the MD Severity Index (MDSI) 20 that captures various levels of MD from 0 to +23 days/month. The MDSI variable was modeled after the eight-question Patient Health Questionnaire (PHQ-8) depression measure; a validated questionnaire used to assess the severity of mental health illness at a population level. 21 In response to the need to examine levels of severity of MD, the objective of the current study was to use the more recently developed MDSI to examine associations between levels of severity of MD and meeting the Department of Health and Human Services (DHHS) PA recommendations.
Methods
This study utilized data from the 2011 BRFSS, a continuous random-digit-dialed telephone survey conducted among non-institutionalized US adults ≥18 years of age. The 2011 BRFSS sample (N = 504 408) included subjects from all 50 states, US territories, and the District of Columbia. For this study, the final sample consisted of 431 313 US adults ≥18 years of age who completed the telephone interview questionnaire.
Physical activity
The methodology and questionnaires employed to assess PA within the 2011 BRFSS has been published elsewhere. 22 Furthermore, these questionnaires have been shown to be both reliable and valid in assessing PA behavior . 23 The dependent variable in this study was meeting the 2008 DHHS PA recommendations 24 which came from the 150 min PA calculated variable: adults that participated in 150 min (or vigorous equivalent minutes) of PA per week. A dichotomized variable was created (≥150 min/wk and <150 min/wk).
Mental distress
The MDSI variable was generated by Johnson et al., 20 and was validated against the 'Anxiety and Depression' five-level MD variable from the 2006 BRFSS. The MDSI variable was specifically created from the question: 'Now thinking about your mental health, which includes stress, depression and problems with emotions, for how many days during the past 30 days was your mental health not good?'. 25 Five categories were created: (0-4 days/month, 5-10 days/month, 11-16 days/month, 17-22 days/month and ≥23 days/month).
MDSI development methods
The development of the MDSI is explained in more detail elsewhere. 20 Briefly, the BRFSS is a state-based, nationwide survey among non-institutionalized adults in households that consists of a core questionnaire (a set of questions about health/behavior topics asked to all participants nationwide) and one or more optional modules (sets of questions about specific health/behavior topics that US state agencies have the option to include in the state-level survey instrument). The Anxiety and Depression module (ADM) is an optional module that contains eight mental health questions from the PHQ-8. The ADM questions have been used in the literature to create a five-level index of MD severity. 21 States are not required to include the ADM in state-level questionnaires and the ADM has never been included in all state-level BRFSS questionnaires in a single year; therefore, one cannot utilize a nationwide index of MD severity. In contrast, a single MD question has been included in the BRFSS core questionnaire nationwide every year since 1993. 26, 27 Historically, the core MD question has appeared in the published literature as a dichotomized variable indicating whether or not a participant has frequent MD (14 or more poor mental health days out of the past 30 days). The MDSI was created to provide a five-level index of MD severity that is internally consistent with the MDSI formulated using the ADM. The MDSI has two distinct advantages over the existing MD variables: it can be utilized for all BRFSS participants nationwide since 1993 that provided valid responses to the core mental health question, and it is a five-level index of MD instead of a dichotomized indicator of frequent MD. The MDSI was created using 2006 BRFSS data because a large number of states (34) included the ADM that survey year. The MDSI has acceptable internal consistency compared to the ADM-based severity index variable (Cronbach's α = 0.72).
Covariates
Three categories were created for age: 18-34, 35-54 and ≥55 years of age. Gender was dichotomized: male or female. Four categories for race/ethnicity were used: non-Hispanic white, non-Hispanic black, Mexican American and other. Education was divided into four categories: high school, high school graduate or GED, some college and college graduate. Body mass index (BMI) was categorized into four levels: underweight (<18.5 kg/m 
Statistical analysis
The data in this study were initially managed using SAS 9.2.
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SAS was used to conduct complex variable recodes and data coding validation. SAS-callable SUDAAN 29 was used to conduct the resultant analyses, incorporating sampling weights within the context of the sampling design inherent to the BRFSS. Non-overlapping 95% confidence intervals (CI) with corresponding two-sided P-values illustrate significance (P < 0.05). Logistic regression (PROC RLOGIST) analysis was used to test the null hypotheses that individual regression coefficients are equal to zero for each level of the MDSI, compared to the referent. The regression model created included the primary dependent variable MD adjusting for age, race, gender, education, BMI and MD.
Results Table 1 illustrates the prevalence of meeting the DHHS PA recommendations by independent variables. A significant inverse trend was seen across categories of MDSI (P < 0.001). The prevalence of meeting the DHHS PA recommendations was 53.38% (53.04-53.72%) in subjects reporting 0-4 days/month of MD, 50.42% (49.35-51.48%) 5-10 days/month, 44.33% (42.67-46.01%) 11-16 days/month, 41.09% (38.81-43.42%) 17-22 days/month and 38.77% (37.62-39.94%) in subjects reporting ≥23 days/month. Across covariates, significant inverse trends were revealed across increasing BMI (with the exception of 'underweight') (P < 0.001) and education (P < 0.001). Those who were non-Hispanic black (P < 0.001), Mexican American (P < 0.001) and other (P < 0.001) had significantly lower reported prevalence of meeting the PA recommendations compared to non-Hispanic white. Significant differences were also found comparing males to females (P < 0.001), with males reporting higher prevalence of meeting the PA recommendations. Table 2 illustrates the results of the logistic regression analysis. Compared to a referent group of adults reporting 0-4 days/month of MD, those reporting 5-10 (OR = 0.92, 95% The results of this study revealed a significant inverse doseresponse relationship between increasing levels of MD severity and reporting meeting the DHHS PA recommendations. These results add to the limited literature investigating the associations between higher levels of MD severity and PA participation. 7,9,12,13 Independent of age, Brown et al.
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showed significant differences in odds of reporting ≥14 days/month of FMD when reporting any level of PA compared to those reporting no PA. Following stratification by gender, results remained significant. Strine et al. 9 showed that subjects reporting having FMD were significantly more likely (OR = 1.6, CI: 1.5-1.7) to report no PA participation. It is important to note that the previous literature examining PA and MD has utilized the common ≥14 days/month cutpoint to denote FMD. 7, 9, 12, 13 Our results expand on this by providing insight via a more liberal categorization of MD using the MDSI.
What this study adds
These results provide an avenue to further expand on the population-based associations between MD and PA beyond the PA recommendations. More specifically, the use of the MDSI could provide a better illustration of the dose-response association between MD and muscular strengthening activities (MSA), participation in PA at higher intensities, as well as overall total volume of PA; all of which are strongly associated with better cardiometabolic profiles [30] [31] [32] [33] and lower risk for disease. 34 For example, using data from the 2000 BRFSS, Sciamanna et al. 35 found significantly lower odds for reporting ≥14 days/month of FMD in those reporting participation in MSA compared to none. However, after adjustment for covariates, the results were non-significant. Due to the use of the dichotomized FMD variable, it is unable to be determined if differences exist across a more liberal categorization of MD; which could be further examined using the MDSI variable.
Several studies have revealed positive associations between MD and CVD, [4] [5] [6] diabetes, 4-6 smoking and increased alcohol consumption, 7-9 hypertension, 6,8 hypercholesterolemia and obesity. 8 It is important to note that each of the aforementioned studies have utilized the dichotomous, 14-day cut-point when analyzing MD. While this cut-point is similar to that used for clinical depression diagnosis, it can be speculated that those reporting a greater frequency of MD (i.e. 30 versus 14 days/ month) may be different; physiologically, psychologically, and, as the current study has shown, in their PA behavior. These relationships need further investigation; however, given the emerging data, clinically meaningful cutpoints play an important role in mental health epidemiology as well as for accurate assessment, diagnosis and treatment planning.
As stated earlier, the MDSI variable was modeled after the PHQ-8 21 taken from the ADM, which assesses the number of days over a 2-week period a participant experienced a depressive or mental health symptom. These days are converted to a range of scores to denote a five-category mental health severity ranging from none to severe illness. 36 A limitation to the use of this original method is that it is not a continuous part of the core questionnaire used each cycle; it is optional and used sporadically by states. This 19 reported that MD at 6 days has both stronger associations with clinical depression and poor mental health compared to the traditional 14-day cut-point. As shown in our study, those with 5-10 days of MD are significantly less likely to be meeting the recommended volumes of PA, which is associated with increased odds of deleterious conditions such as metabolic syndrome. 37 These results warrant the use of more conservative approach in MD epidemiology as associations with clinical health outcomes may be different across increasing frequency.
Strengths/limitations of this study
The strengths of our study include strong external validity owing to the use of a large representative sample of US adults. Also, our results support previous studies demonstrating an inverse relationship between MD and PA participation. Moreover, the novel approach to this study design, characterized by a five-category MDSI variable allows for greater insight into these associations. The limitations of our study include the cross-sectional study design, which does not allow for causation to be established between variables, and the use of questionnaires for the assessment of variables, which is subject to reporting and recall bias as well as the social desirability effect; which may lead to an overestimation of PA as well as issues with under-reporting MD frequency. Lastly, the BRFSS sample is also limited to non-institutionalized people only and subjects without phones are not eligible for participation. However, the use of the sampling weights adjusts for potential issues associated with noncoverage.
In conclusion, the use of the new MDSI variable revealed a significant inverse dose-response relationship between MD and meeting the current PA guidelines. MD has been shown to be associated with increased risk for many adverse health conditions as well as harmful behaviors. However, future research is needed to clarify the extent to which frequency of MD relates to these clinical outcomes. The use of the MDSI can assist in understanding these relationships at the population level as well as providing greater understanding of potential points of clinical intervention to minimize poor health outcomes.
